Monte Rosa Therapeutics Inc. (GLUE) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Monte Rosa Therapeutics I...

    NASDAQ: GLUE · Real-Time Price · USD
    7.74
    0.11 (1.44%)
    At close: Oct 03, 2025, 3:59 PM
    7.61
    -1.68%
    After-hours: Oct 03, 2025, 07:38 PM EDT

    Monte Rosa Therapeutics Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -72.7M -135.35M -108.5M -73.96M
    Depreciation & Amortization
    		 8.12M 6.22M 3.75M 2.13M
    Stock-Based Compensation
    		 18.13M 16.67M 11.66M 5.2M
    Other Working Capital
    		 84.81M 64.81M -1.39M 6.99M
    Other Non-Cash Items
    		 -2.95M -3.81M 2.76M 960K
    Deferred Income Tax
    		 n/a n/a n/a 17K
    Change in Working Capital
    		 91.4M 72.47M -2.13M 6.29M
    Operating Cash Flow
    		 42M -43.8M -92.47M -59.36M
    Capital Expenditures
    		 -3.99M -19.04M -12.91M -9.73M
    Cash Acquisitions
    		 n/a 62K 109K 79K
    Purchase of Investments
    		 -230.36M -103.15M -384.42M n/a
    Sales Maturities Of Investments
    		 189.9M 210.93M 178M n/a
    Other Investing Acitivies
    		 n/a n/a n/a n/a
    Investing Cash Flow
    		 -44.45M 88.8M -219.22M -9.65M
    Debt Repayment
    		 n/a n/a n/a n/a
    Common Stock Repurchased
    		 -641K n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 98.59M n/a 411K -3.19M
    Financial Cash Flow
    		 98.89M 27.49M 20.47M 377.56M
    Net Cash Flow
    		 96.44M 72.49M -291.22M 308.55M
    Free Cash Flow
    		 38.01M -62.84M -105.38M -69.09M

    Add to Watchlist